Abstract:Objective To detect mutations of K-ras oncogene in portal vein blood of patients with colorectal cancer, and to find out the relationship between mutated K-ras oncogene and liver metastases in colorectal cancer. Methods Forty-eight patients with colorectal cancer were screened for the mutations of K-ras oncogene in tissue samples from their tumors, portal vein blood, proximally adjacent mucosa and 8metastatic liver biopsies by real-time fluorescence quantitative polymerase chain reaction (PCR) and DNA sequencing. The results were analyzed with their clinical data. Results Sixteen of the 48 patients with colorectal cancer had K-ras point mutations at codon 12 in their portal vein blood, and 17 of 48 patients had K-ras mutations in their primary tumors, but only 4 of 48 patients had K-ras mutations in proximally adjacent mucosa. There was no significant difference in rate of K-ras mutation between tumor tissues and portal vein blood (P ＞ 0. 05 ), but significant difference was found between the tumor tissue and the proximally adjacent mucosa ( P ＜0. 05 ). The rate of K-ras mutations in portal vein blood of colorectal cancer with liver metastases (70. 0% ) was higher than that of without liver metastases (23.7%). Sixteen cases of mutated K-ras in portal vein blood showed mutations in tumor tissues. Patients without mutated K-ras in tumor tissue had no mutations in their portal vein blood and proximally adjacent mucosa. In 5 of 8 patients with simultaneous liver metastasis, mutated K-ras oncogenes were detected in portal vein blood, and the type of K-ras mutation detected in the tumor tissue was accord with that in metastatic liver biopsies. Two patients with mutated K-ras detected in their portal vein blood had no liver metastases during perioperation, but liver metastases were diagnosed by CT at the postoperative month 6 and 9 respectively. The main types of K-ras mutations at codon 12 included GGT to GAT and GGT to GTT. No one had point mutation at codon 13. Conclusion Mutated K-ras detected in both cancer tissue and portal vein blood may indicate livermetastases from colorectal cancer.

Detection of K-ras gene mutations in bile and bile duct brushings for diagnosis of cholangiocarcinamas

Values of Mutations of K-ras Oncogene at Codon 12 in Detection of Pancreatic Cancer: 15-Year Experience

Detection Of Kras Gene Mutations In Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy For Improving Pancreatic Cancer Diagnosis

Detection of K-ras Gene Mutation at Codon 12 by Pancreatic Duct Brushing for Pancreatic Cancer.

Detection of the point mutation of k-ras gene in sputum sample and its diagnostic value for lung cancer

The Diagnostic Value of the K-ras Mutation Detection of Endoscopic Ultrasound-Guided Fine Needle Aspiration Specimen for Pancreatic Carcinoma

Correlation of Cholangiocarcinoma and K-ras Gene Mutation of Bile Duct Tissues

K-Ras Gene Mutation in the Diagnosis of Ultrasound Guided Fine-Needle Biopsy of Pancreatic Masses

Combined detection of p16 aberrant methylation and K-ras gene mutation in pancreatic juice for diagnosis of pancreatic cancer

K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.

A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer

Detection of K-ras Gene Mutations in Cancer Tissues, Preoperative Carcinoembryonic Antigen in Serums of Patients with Colorectal Cancer and Their Correlation with Clinical Pathological Characteristics

The Value of K-ras Gene Point Mutation in the Diagnosis of Pancreatic Adenocarcinoma

[Experiment Study on the Diagnostic Value of Bile K-ras Gene Mutation Responsible to the Hepatic Metastasis of Pancreatic Cancer].

Incidence and Clinical Significance of K-Ras Mutation in Plasma of Patients with Biliary Carcinoma

A Novel Nanoprobe-Based Assay for Detecting K-ras Mutations in Plasma and Stool Samples from Patients with Pancreatic Cancer: Value in Diagnosis and Prognosis Evaluation

Detection of K-ras gene mutation in colorectal tumor and relationship with clinicopathological features

The relationship between K-ras gene mutation with clinicopathological and prognosis in gallbladder carcinoma

A Prospective Study of Detection of Pancreatic Carcinoma by Combined Plasma K -Ras Mutations and Serum CA19-9 Analysis

Relationship between K-ras oncogene mutations in portal vein blood of patients with colorectal cancer and liver metastases

[Significance of Detection of K-ras Gene Mutations and CA19-9 in Serum for Diagnosis of Pancreatic Carcinoma].